Online Only Articles

CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia

CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
CLIP – Childhood Leukemia Investigation Prague, Prague, Czech Republic;Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;University Hospital Motol, Prague, Czech Republic
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
CLIP – Childhood Leukemia Investigation Prague, Prague, Czech Republic;Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;University Hospital Motol, Prague, Czech Republic
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
Department of Pediatric Hematology and Oncology, St. Anna Children’s Hospital Medical University of Vienna, Vienna, Austria
CLIP – Childhood Leukemia Investigation Prague, Prague, Czech Republic;Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
Department of Woman’s and Child’s Health, Laboratory of Pediatric Oncohematology, University of Padova, Padova, Italy
Department of Woman’s and Child’s Health, Laboratory of Pediatric Oncohematology, University of Padova, Padova, Italy
Department of Oncology and Children’s Research Center, University Children’s Hospital Zürich, Zürich, Switzerland
Department of Pediatrics, University of Milano-Bicocca, Fondazione Tettamanti – Centro Ricerca M. Tettamanti, Monza, Italy
Department of Hematology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Pediatric Hematology Oncology, Schneider Children’s Medical Center, Petah-Tikva, Israel
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
CLIP – Childhood Leukemia Investigation Prague, Prague, Czech Republic;Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;University Hospital Motol, Prague, Czech Republic
Department of Pediatric Hematology and Oncology, St. Anna Children’s Hospital Medical University of Vienna, Vienna, Austria
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
CLIP – Childhood Leukemia Investigation Prague, Prague, Czech Republic;Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;University Hospital Motol, Prague, Czech Republic
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria;Department of Pediatric Hematology and Oncology, St. Anna Children’s Hospital Medical University of Vienna, Vienna, Austria
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
Vol. 104 No. 8 (2019): August, 2019 https://doi.org/10.3324/haematol.2018.214353